1-3 of 3
Richard Beers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors

Ronit Mazor, Jingli Zhang, Laiman Xiang, Selamawit Addissie, Prince Awuah, Richard Beers, Raffit Hassan, Ira Pastan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12): 2789–2796.
DOI: https://doi.org/10.1158/1535-7163.MCT-15-0532
Published: 06 December 2015
View article
PDF
Includes: Supplementary data
Journal Articles

A Recombinant Immunotoxin against the Tumor-Associated Antigen Mesothelin Reengineered for High Activity, Low Off-Target Toxicity, and Reduced Antigenicity

John E. Weldon, Laiman Xiang, Jingli Zhang, Richard Beers, Dawn A. Walker, Masanori Onda, Raffit Hassan, Ira Pastan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (1): 48–57.
DOI: https://doi.org/10.1158/1535-7163.MCT-12-0336
Published: 13 January 2013
View article
PDF
Includes: Supplementary data
Journal Articles

Bivalent Disulfide-stabilized Fragment Variable Immunotoxin Directed against Mesotheliomas and Ovarian Cancer

Tapan K. Bera, Juanita Williams-Gould, Richard Beers, Partha Chowdhury, Ira Pastan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2001) 1 (2): 79–84.
Published: 01 December 2001
View article
PDF